BCL2 and neoplasm: As shown in Figure 3 (a, b) BMC of orlistat-administered tumor-bearing hosts showed an inhibition in the expression of pro-apoptotic Caspase-3 and Bax proteins accompanied by an increased expression of anti-apoptotic Bcl2.